Mitochondria-associated endoplasmic reticulum membranes as a therapeutic target for cardiovascular diseases
- PMID: 38694924
- PMCID: PMC11061472
- DOI: 10.3389/fphar.2024.1398381
Mitochondria-associated endoplasmic reticulum membranes as a therapeutic target for cardiovascular diseases
Abstract
Cardiovascular diseases (CVDs) are currently the leading cause of death worldwide. In 2022, the CVDs contributed to 19.8 million deaths globally, accounting for one-third of all global deaths. With an aging population and changing lifestyles, CVDs pose a major threat to human health. Mitochondria-associated endoplasmic reticulum membranes (MAMs) are communication platforms between cellular organelles and regulate cellular physiological functions, including apoptosis, autophagy, and programmed necrosis. Further research has shown that MAMs play a critical role in the pathogenesis of CVDs, including myocardial ischemia and reperfusion injury, heart failure, pulmonary hypertension, and coronary atherosclerosis. This suggests that MAMs could be an important therapeutic target for managing CVDs. The goal of this study is to summarize the protein complex of MAMs, discuss its role in the pathological mechanisms of CVDs in terms of its functions such as Ca2+ transport, apoptotic signaling, and lipid metabolism, and suggest the possibility of MAMs as a potential therapeutic approach.
Keywords: cardiovascular diseases; coronary atherosclerosis; mitochondria-associated endoplasmic reticulum membrane; myocardial ischemia; therapeutic target.
Copyright © 2024 Ding, Liu, Zhang, Guo, Shang, Liu, Ren and Ma.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Dialogue between mitochondria and endoplasmic reticulum-potential therapeutic targets for age-related cardiovascular diseases.Front Pharmacol. 2024 Jun 13;15:1389202. doi: 10.3389/fphar.2024.1389202. eCollection 2024. Front Pharmacol. 2024. PMID: 38939842 Free PMC article. Review.
-
Mitochondria-Associated Endoplasmic Reticulum Membranes in Cardiovascular Diseases.Front Cell Dev Biol. 2020 Nov 9;8:604240. doi: 10.3389/fcell.2020.604240. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 33240899 Free PMC article. Review.
-
Mitochondria-associated endoplasmic reticulum membranes: A promising toxicity regulation target.Acta Histochem. 2023 Feb;125(2):152000. doi: 10.1016/j.acthis.2023.152000. Epub 2023 Jan 23. Acta Histochem. 2023. PMID: 36696877 Review.
-
Mitochondria-associated endoplasmic reticulum membranes and cardiac hypertrophy: Molecular mechanisms and therapeutic targets.Front Cardiovasc Med. 2022 Oct 20;9:1015722. doi: 10.3389/fcvm.2022.1015722. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36337896 Free PMC article. Review.
-
Mitochondria-Associated Endoplasmic Reticulum Membranes: Inextricably Linked with Autophagy Process.Oxid Med Cell Longev. 2022 Aug 23;2022:7086807. doi: 10.1155/2022/7086807. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 36052160 Free PMC article. Review.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous